Safety and Tolerability Study With Single Ascending Doses of ORM-12741
NCT00693316
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
ORM-12741
Sponsor
Orion Corporation, Orion Pharma